Methods of using biologically active dimerized polypeptide fusions to detect PDGF
AssigneeZymoGenetics, Inc.
InventorsAndrzej Z. Sledziewski, Lillian A. Bell, Wayne R. Kindsvogel
Life of this patent
Estimating the term…
Loading patent…
AssigneeZymoGenetics, Inc.
InventorsAndrzej Z. Sledziewski, Lillian A. Bell, Wayne R. Kindsvogel
Estimating the term…
Methods for producing secreted receptor analogs and biologically active peptide dimers are disclosed. The methods for producing secreted receptor analogs and biologically active peptide dimers utilize a DNA sequence encoding a receptor analog or a peptide requiring dimerization for biological activity joined to a dimerizing protein. The receptor analog includes a ligand-binding domain. Polypeptides comprising essentially the extracellular domain of a human PDGF receptor fused to dimerizing proteins, the portion being capable of binding human PDGF or an isoform thereof, are also disclosed. The polypeptides may be used within methods for determining the presence of and for purifying human PDGF or isoforms thereof.
A method for determining the presence of platelet-derived growth factor (PDGF) or isoforms thereof in a biological sample, comprising:
Dependencies are inferred from the claim text.